DELIVER represents the largest ever trial to address heart failure with preserved ejection fraction
News
EC approval for post-steroid graft-versus-host treatment
Jakavi treats a potentially life-threatening condition which often effects transplant patients
Novartis Kymriah receives EC approval for lymphoma treatment
Approval for Kymriah follows a positive CHMP opinion and is applicable to all 27 EU member states
Isla Visual Record for Surveillance to aid post-surgery wound assessment
Platform will enable patients to monitor and share updates of their post-surgical wound healing
Byondis and Medac link up to commercialise trastuzumab duocarmazine
Byondis and Medac have entered into a license and collaboration agreement for form of targeted chemotherapy
Idorsia’s Quviviq approved for adults with chronic insomnia disorder
The EC’s decision on the insomnia treatment was supported by phase 3 trial results
Insulin glargine meets primary endpoint in Sanofi’s type 1 diabetes study
InRange is the first worldwide multicentre RCT to compare second generation basal insulins
NICE recommend exercise over painkillers for arthritis pain
NICE urges older people to stop routine painkiller use – over 10 million in the UK suffer a form of arthritis or other joint conditions
Scientists to trial world-first long-acting injection for high blood pressure
Long-acting hypertension treatment could provide patients with an injection of medication every six months
New long COVID study highlights key symptoms
Women, those who are obese and those on mechanical ventilation are all more likely to suffer from the effects long-term COVID-19
Study reveals more babies dying of neonatal sepsis
GARDP neonatal sepsis study was carried out in 19 hospitals across four continents
May Measurement Month aims to save more lives than ever
MMM is a global campaign which raises awareness of high blood pressure and its long-term implications
The Steve Morgan Foundation donates £50m to diabetes research
The Foundation also launched a new collaboration with Diabetes UK and the Juvenile Diabetes Research Foundation UK
ViGeneron and Daiichi Sankyo to develop therapy for eye diseases
Follow-on collaboration between ViGeneron and Daiichi Sankyo allows the companies to create and validate vgAAV-based therapeutic candidates
Novartis UK announces new charity partnerships supporting social mobility
Novartis will provide vital volunteering projects, career plans for young people and financial support to local charities
